Answers are grounded in this paper and cite their sources.
This review focuses on the characteristics of vitiligo with an emphasis on diagnosis and treatment options. Vitiligo is a chronic skin disease affecting approximately 0.4% of the world's population. It can lead to stigmatization and a decrease in quality of life. The diagnosis is often straightforward, but there are many other skin conditions which can cause loss of pigmentation. The treatment options have been scarce until 2022 when the first treatment was approved, and today several other treatments are in clinical trials.
No takes yet. Share an insight, caveat, or question.
Haulrig et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: